Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment
F Zeni, B Freeman, C Natanson - Critical care medicine, 1997 - journals.lww.com
This issue of Critical Care Medicine reports the results of the second phase III double-blinded
multicenter trial of interleukin-1 receptor antagonist (IL-1ra)[1]. In a clear presentation and …
multicenter trial of interleukin-1 receptor antagonist (IL-1ra)[1]. In a clear presentation and …
Does bicarbonate therapy improve the management of severe diabetic ketoacidosis?
A Viallon, F Zeni, P Lafond, C Venet, B Tardy… - Critical care …, 1999 - journals.lww.com
Objective: The use of bicarbonates in the treatment of severe diabetic ketoacidosis remains
controversial, especially regarding the benefit/risk ratio. The aim of this study was to assess …
controversial, especially regarding the benefit/risk ratio. The aim of this study was to assess …
Doppler-based renal resistive index for prediction of renal dysfunction reversibility: a systematic review and meta-analysis
S Ninet, D Schnell, A Dewitte, F Zeni, F Meziani… - Journal of critical …, 2015 - Elsevier
Background and objectives Doppler-based renal resistive index (RI) might help in
distinguishing transient from persistent acute kidney injury (AKI). The main objective of these …
distinguishing transient from persistent acute kidney injury (AKI). The main objective of these …
Acute respiratory distress syndrome and risk of AKI among critically ill patients
…, S Jamali, B Souweine, F Zeni… - Clinical Journal of the …, 2014 - journals.lww.com
Results This study enrolled 8029 patients, including 1879 patients with ARDS. AKI occurred
in 31.3% of patients and was more common in patients with ARDS (44.3% versus 27.4% in …
in 31.3% of patients and was more common in patients with ARDS (44.3% versus 27.4% in …
Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines
A Viallon, F Zeni, V Pouzet, C Lambert, S Quenet… - Intensive care …, 2000 - Springer
Objective: To assess the potential role of procalcitonin and pro-inflammatory cytokines, TNF-α,
and IL-6, in the diagnosis of spontaneous bacterial peritonitis (SBP). Design: Prospective …
and IL-6, in the diagnosis of spontaneous bacterial peritonitis (SBP). Design: Prospective …
Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion
…, CA Arthaud, MA Eyraud, F Zéni… - Clinical …, 2012 - Elsevier
… The box-and-whiskers plots (A–F) show both the range of soluble CD62p (A), PF4 (B),
RANTES (C), sCD40L (D), PDGF-AB (E), and sCD14 (F) concentrations in PRP supernatants (ng/…
RANTES (C), sCD40L (D), PDGF-AB (E), and sCD14 (F) concentrations in PRP supernatants (ng/…
Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients
…, G Aubert, A Ros, A Dumont, F Lucht, F Zeni… - Intensive care …, 2001 - Springer
Objective: To investigate the respective contribution of endogenous and exogenous transmission
of Pseudomonas aeruginosa in the colonization of lungs in the mechanically ventilated …
of Pseudomonas aeruginosa in the colonization of lungs in the mechanically ventilated …
High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis
A Viallon, F Zeni, C Lambert, B Pozzetto… - Clinical infectious …, 1999 - academic.oup.com
It was shown in children that serum procalcitonin was the best marker to use to differentiate
bacterial from viral meningitis. To evaluate procalcitonin in the diagnosis of acute bacterial …
bacterial from viral meningitis. To evaluate procalcitonin in the diagnosis of acute bacterial …
[HTML][HTML] The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs)
L Sessa, E Gatti, F Zeni, A Antonelli, A Catucci, M Koch… - PloS one, 2014 - journals.plos.org
The human receptor for advanced glycation endproducts (RAGE) is a multiligand cell surface
protein belonging to the immunoglobulin superfamily, and is involved in inflammatory and …
protein belonging to the immunoglobulin superfamily, and is involved in inflammatory and …
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial
…, F Zeni, D Dreyfuss, JP Mira, F de Vathaire… - Critical care …, 1994 - journals.lww.com
Objective: To evaluate the safety and efficacy of a natural platelet-activating factor receptor
antagonist, BN 52021 (Ginkgolide B), in the treatment of patients with sepsis syndrome. …
antagonist, BN 52021 (Ginkgolide B), in the treatment of patients with sepsis syndrome. …